SCD5 expression correlates with prognosis and response to neoadjuvant chemotherapy in breast cancer

SCD5 expression correlates with prognosis and response to neoadjuvant chemotherapy in breast cancer

Abstract Neoadjuvant chemotherapy (NACT) represents a standard option for breast cancer. Unfortunately, about 55–80% of breast cancer patients do not have a favorable response to chemotherapy. Highly specific tumor biomarker that can predict the pathological response to neoadjuvant chemotherapy is l...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Weipeng Zhao, Linlin Sun, Xichuan Li, Jun Wang, Ye Zhu, Yan Jia, Zhongsheng Tong
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/fd1f65916da6499290144a7fb58996d1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares